Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians. Medscape, LLC designates this educational activity for a maximum of 1.0
Upon completion of this activity, participants will be able to:
Identify common infections associated with β-herpesviruses
Specify β-herpesviruses isolated from children in the current study
Describe clinical characteristics of β-herpesvirus infections in the current study
List factors associated with higher rates of infection with human herpesvirus in the current study
To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions and earn continuing medical education (CME) credit, please go to
Which of the following statements about β-herpesviruses is
A. Infection is not common until late adolescence
B. Infection with cytomegalovirus (CMV) promotes symptoms similar to mononucleosis
C. Human herpesvirus (HHV)-6B is the cause of fifth disease
D. HHV-7 is the virus responsible for most cases of roseola
Which of the following β-herpesviruses were detected in the patient cohort of the current study?
A. HHV-6B and HHV-6A
B. CMV and HHV-7
C. HHV-6B and CMV
D. HHV-6A and HHV-7
Which of the following statements about infection data in the current study is
A. The etiology of most patients’ fever was discovered during hospitalization
B. Infection with β-herpesviruses occurred at a higher frequency among children with cancer compared with those with solid organ transplant
C. Fever was generally higher among children infected with β-herpesviruses
D. HHV-6B infection was likely a reactivation of previous infection among cancer patients
Which cancer factors promoted infection with HHV-6B in the current study?
A. Solid organ tumor and over 6 months since the initiation of immune suppression
B. Solid organ tumor and less than 6 months since the initiation of immune suppression
C. Leukemia and less than 6 months since the initiation of immune suppression
D. Leukemia and more than 6 months since the initiation of immune suppressionStrongly Disagree Strongly Agree 1 2 3 4 5 Strongly Disagree Strongly Agree 1 2 3 4 5 Strongly Disagree Strongly Agree 1 2 3 4 5 Strongly Disagree Strongly Agree 1 2 3 4 5